CA
VCYT icon

Continuum Advisory’s Veracyte VCYT Stock Holding History

Continuum Advisory’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-58
Closed -$1.72K – 1526
2025
Q1 		$1.72K Sell
58
-7
-11% -$267 ﹤0.01% 1389
2024
Q4 		$2.57K Buy
65
+12
+23% +$454 ﹤0.01% 1338
2024
Q3 		$1.96K Buy
53
+37
+231% +$1.04K ﹤0.01% 1432
2024
Q2 		$347 Hold
16
– – ﹤0.01% 1649
2024
Q1 		$330 Buy
+16
New +$390 ﹤0.01% 1650

Other funds holding VCYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Continuum Advisory's VCYT Position: Q2 2025 in Review

Continuum Advisory sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 58 shares — an estimated $1.72K sold.

Continuum Advisory first reported a position in VCYT in Q1 2024 and held it in 5 quarters. The position peaked at $2.57K in Q4 2024. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.

  • Continuum Advisory reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 58 Veracyte shares in Q2 2025, an estimated $1.72K.
  • Continuum Advisory first reported a position in Veracyte in Q1 2024 and held it in 5 quarters.
  • Continuum Advisory's Veracyte position peaked at $2.57K in Q4 2024.
  • 278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.